Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Kolkata Rains: Rains wreak havoc before Durga Puja, killing 7 people, disrupting normal life
Torrential rains lashed Kolkata and its surrounding areas overnight on Tuesday, disrupting normal
Rajasthan Royals and Delhi Capitals will try to forget their defeat in the last match and make a
People had not yet recovered from the incident in Kerala's Kasargod and another new trouble came
Voting for the seventh phase of Lok Sabha elections is to be held on June 1. On th
Coronavirus cases are continuously increasing in India. Every day a new jump is being seen in the
Who is Alia Bhatt's former PA Vedika Prakash Shetty, accused of fraud of Rs 77 lakh; arrested
Juhu police has arrested Bollywood actress Alia Bhatt's former personal assistant (PA) Vedika Pra
The Supreme Court has sought a response from the Election Commission in the matter of the Electio
Bollywood's 'Dabangg' actress Sonakshi Sinha is going to tie the knot soon. Sonakshi will become
The Special Investigation Team (SIT) arrived at the Noida Authority's Sector 6 office today to in
Although the situation is not clear due to the Supreme Court's stance on the Waqf Amendment Act,
